Alejandro Dorenbaum
Directeur Technique/Scientifique/R&D chez RENEO PHARMACEUTICALS, INC.
Fortune : - $ au 30/06/2024
Profil
Dr. Alejandro Dorenbaum, MD, is a Chief Medical Officer at Reneo Pharmaceuticals, Inc. and a Clinical Professor-Pediatrics at Stanford University School of Medicine.
Dr. Dorenbaum was previously employed as a Chief Medical Officer by Allakos, Inc., a Chief Medical Officer by Lumena Pharmaceuticals, Inc., a Medical Director by Genentech, Inc., a Senior Director-Clinical Affairs by BioMarin Pharmaceutical, Inc., a Director-Clinical Development by Chiron Corp., and an Assistant Clinical Professor-Pediatrics by The University of California, San Francisco.
He received his doctorate degree from Universidad Nacional Autónoma de México.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de Alejandro Dorenbaum
| Sociétés | Poste | Début |
|---|---|---|
| RENEO PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2018 |
| Stanford University School of Medicine | Corporate Officer/Principal | - |
Anciens postes connus de Alejandro Dorenbaum
| Sociétés | Poste | Fin |
|---|---|---|
| ALLAKOS INC. | Directeur Technique/Scientifique/R&D | 01/06/2017 |
Lumena Pharmaceuticals, Inc.
 Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lumena Pharmaceuticals, Inc. developed oral therapeutics for rare liver diseases. The firm was engaged in the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, such as nonalcoholic steatohepatitis. The company was founded by Bronislava Gedulin and Michael G. Grey in January 2011 and was headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | 30/06/2014 |
| BIOMARIN PHARMACEUTICAL INC. | Directeur Technique/Scientifique/R&D | 01/01/2009 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01/01/2003 |
| The University of California, San Francisco | Corporate Officer/Principal | 01/01/2000 |
Formation de Alejandro Dorenbaum
| Universidad Nacional Autónoma de México | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| ALLAKOS INC. | Health Technology |
| RENEO PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Lumena Pharmaceuticals, Inc.
Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lumena Pharmaceuticals, Inc. developed oral therapeutics for rare liver diseases. The firm was engaged in the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, such as nonalcoholic steatohepatitis. The company was founded by Bronislava Gedulin and Michael G. Grey in January 2011 and was headquartered in San Diego, CA. | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
